ID   DHX30_HUMAN             Reviewed;        1194 AA.
AC   Q7L2E3; A8K5F1; O94965; Q7Z753; Q96CH4; Q9NUQ0;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   27-MAR-2024, entry version 177.
DE   RecName: Full=ATP-dependent RNA helicase DHX30 {ECO:0000305};
DE            EC=3.6.4.13 {ECO:0000269|PubMed:29100085};
DE   AltName: Full=DEAH box protein 30;
GN   Name=DHX30; Synonyms=DDX30, KIAA0890;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBUNIT, IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=16825194; DOI=10.1074/jbc.m604501200;
RA   Wang Y., Bogenhagen D.F.;
RT   "Human mitochondrial DNA nucleoids are linked to protein folding machinery
RT   and metabolic enzymes at the mitochondrial inner membrane.";
RL   J. Biol. Chem. 281:25791-25802(2006).
RN   [5]
RP   INTERACTION WITH AGO1 AND AGO2.
RX   PubMed=17932509; DOI=10.1038/sj.embor.7401088;
RA   Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M.,
RA   Urlaub H., Meister G.;
RT   "Proteomic and functional analysis of Argonaute-containing mRNA-protein
RT   complexes in human cells.";
RL   EMBO Rep. 8:1052-1060(2007).
RN   [6]
RP   SUBCELLULAR LOCATION, ASSOCIATION WITH MITOCHONDRIAL DNA, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18063578; DOI=10.1074/jbc.m708444200;
RA   Bogenhagen D.F., Rousseau D., Burke S.;
RT   "The layered structure of human mitochondrial DNA nucleoids.";
RL   J. Biol. Chem. 283:3665-3675(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-380, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH GRSF1; DDX28; FASTKD2 AND
RP   FASTKD5, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25683715; DOI=10.1016/j.celrep.2015.01.030;
RA   Antonicka H., Shoubridge E.A.;
RT   "Mitochondrial RNA granules are centers for post-transcriptional RNA
RT   processing and ribosome biogenesis.";
RL   Cell Rep. 10:920-932(2015).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   STRUCTURE BY NMR OF 42-148.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the double-stranded RNA binding domain in KIAA0890
RT   protein.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [17]
RP   INVOLVEMENT IN NEDMIAL, VARIANTS NEDMIAL HIS-493; ARG-562; ASP-781;
RP   TRP-782; CYS-785 AND HIS-785, CHARACTERIZATION OF VARIANTS NEDMIAL HIS-493;
RP   ARG-562; ASP-781; TRP-782; CYS-785 AND HIS-785, FUNCTION, CATALYTIC
RP   ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=29100085; DOI=10.1016/j.ajhg.2017.09.014;
RG   DDD study;
RG   C4RCD Research Group;
RA   Lessel D., Schob C., Kuery S., Reijnders M.R.F., Harel T., Eldomery M.K.,
RA   Coban-Akdemir Z., Denecke J., Edvardson S., Colin E., Stegmann A.P.A.,
RA   Gerkes E.H., Tessarech M., Bonneau D., Barth M., Besnard T., Cogne B.,
RA   Revah-Politi A., Strom T.M., Rosenfeld J.A., Yang Y., Posey J.E.,
RA   Immken L., Oundjian N., Helbig K.L., Meeks N., Zegar K., Morton J.,
RA   Schieving J.H., Claasen A., Huentelman M., Narayanan V., Ramsey K.,
RA   Brunner H.G., Elpeleg O., Mercier S., Bezieau S., Kubisch C., Kleefstra T.,
RA   Kindler S., Lupski J.R., Kreienkamp H.J.;
RT   "De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a
RT   Neurodevelopmental Disorder.";
RL   Am. J. Hum. Genet. 101:716-724(2017).
RN   [18]
RP   VARIANTS NEDMIAL HIS-493; ARG-562 AND TRP-782.
RX   PubMed=28327206; DOI=10.1186/s13073-017-0412-6;
RA   Eldomery M.K., Coban-Akdemir Z., Harel T., Rosenfeld J.A., Gambin T.,
RA   Stray-Pedersen A., Kuery S., Mercier S., Lessel D., Denecke J.,
RA   Wiszniewski W., Penney S., Liu P., Bi W., Lalani S.R., Schaaf C.P.,
RA   Wangler M.F., Bacino C.A., Lewis R.A., Potocki L., Graham B.H.,
RA   Belmont J.W., Scaglia F., Orange J.S., Jhangiani S.N., Chiang T.,
RA   Doddapaneni H., Hu J., Muzny D.M., Xia F., Beaudet A.L., Boerwinkle E.,
RA   Eng C.M., Plon S.E., Sutton V.R., Gibbs R.A., Posey J.E., Yang Y.,
RA   Lupski J.R.;
RT   "Lessons learned from additional research analyses of unsolved clinical
RT   exome cases.";
RL   Genome Med. 9:26-26(2017).
CC   -!- FUNCTION: RNA-dependent helicase (PubMed:29100085). Plays an important
CC       role in the assembly of the mitochondrial large ribosomal subunit
CC       (PubMed:25683715, PubMed:29100085). Required for optimal function of
CC       the zinc-finger antiviral protein ZC3HAV1 (By similarity). Associates
CC       with mitochondrial DNA (PubMed:18063578). Involved in nervous system
CC       development and differentiation through its involvement in the up-
CC       regulation of a number of genes which are required for neurogenesis,
CC       including GSC, NCAM1, neurogenin, and NEUROD (By similarity).
CC       {ECO:0000250|UniProtKB:Q5BJS0, ECO:0000250|UniProtKB:Q99PU8,
CC       ECO:0000269|PubMed:18063578, ECO:0000269|PubMed:25683715,
CC       ECO:0000269|PubMed:29100085}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC         Evidence={ECO:0000269|PubMed:29100085};
CC   -!- SUBUNIT: Identified in a complex with TFAM and SSBP1. Interacts with
CC       AGO1 and AGO2. Interacts (via N-terminus) with ZC3HAV1 (via N-terminal
CC       domain) in an RNA-independent manner (By similarity). Found in a
CC       complex with GRSF1, DDX28, FASTKD2 and FASTKD5 (PubMed:25683715).
CC       {ECO:0000250|UniProtKB:Q5BJS0, ECO:0000269|PubMed:16825194,
CC       ECO:0000269|PubMed:17932509, ECO:0000269|PubMed:25683715}.
CC   -!- INTERACTION:
CC       Q7L2E3; P13569: CFTR; NbExp=5; IntAct=EBI-1211456, EBI-349854;
CC       Q7L2E3; Q96C10: DHX58; NbExp=2; IntAct=EBI-1211456, EBI-744193;
CC       Q7L2E3; P19525: EIF2AK2; NbExp=4; IntAct=EBI-1211456, EBI-640775;
CC       Q7L2E3; Q9Y6K5: OAS3; NbExp=2; IntAct=EBI-1211456, EBI-6115729;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:29100085}.
CC       Mitochondrion {ECO:0000269|PubMed:16825194,
CC       ECO:0000269|PubMed:29100085}. Mitochondrion matrix, mitochondrion
CC       nucleoid {ECO:0000269|PubMed:16825194, ECO:0000269|PubMed:18063578,
CC       ECO:0000269|PubMed:25683715}. Note=Localizes to mitochondrial RNA
CC       granules found in close proximity to the mitochondrial nucleoids
CC       (PubMed:16825194, PubMed:25683715). Relocalizes to stress granules upon
CC       heat stress (PubMed:29100085). {ECO:0000269|PubMed:16825194,
CC       ECO:0000269|PubMed:25683715, ECO:0000269|PubMed:29100085}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q7L2E3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7L2E3-2; Sequence=VSP_022118;
CC       Name=3;
CC         IsoId=Q7L2E3-3; Sequence=VSP_036891, VSP_036892;
CC   -!- PTM: [Isoform 2]: Phosphorylated on Ser-15.
CC       {ECO:0007744|PubMed:18220336}.
CC   -!- DISEASE: Neurodevelopmental disorder with variable motor and language
CC       impairment (NEDMIAL) [MIM:617804]: An autosomal dominant
CC       neurodevelopmental disorder characterized by global developmental
CC       delay, intellectual disability, speech impairment and gait
CC       abnormalities. {ECO:0000269|PubMed:28327206,
CC       ECO:0000269|PubMed:29100085}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DEAH subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74913.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA92071.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB020697; BAA74913.2; ALT_INIT; mRNA.
DR   EMBL; AK002076; BAA92071.1; ALT_SEQ; mRNA.
DR   EMBL; AK291266; BAF83955.1; -; mRNA.
DR   EMBL; BC014237; AAH14237.1; -; mRNA.
DR   EMBL; BC015029; AAH15029.1; -; mRNA.
DR   EMBL; BC020126; AAH20126.1; -; mRNA.
DR   EMBL; BC038417; AAH38417.1; -; mRNA.
DR   CCDS; CCDS2759.1; -. [Q7L2E3-1]
DR   PIR; E56236; E56236.
DR   RefSeq; NP_055781.2; NM_014966.3. [Q7L2E3-3]
DR   RefSeq; NP_619520.1; NM_138615.2. [Q7L2E3-1]
DR   RefSeq; XP_011531796.1; XM_011533494.2. [Q7L2E3-1]
DR   RefSeq; XP_011531797.1; XM_011533495.1.
DR   RefSeq; XP_016861406.1; XM_017005917.1.
DR   PDB; 2DB2; NMR; -; A=42-147.
DR   PDBsum; 2DB2; -.
DR   AlphaFoldDB; Q7L2E3; -.
DR   SMR; Q7L2E3; -.
DR   BioGRID; 116571; 533.
DR   CORUM; Q7L2E3; -.
DR   IntAct; Q7L2E3; 163.
DR   MINT; Q7L2E3; -.
DR   STRING; 9606.ENSP00000405620; -.
DR   ChEMBL; CHEMBL4105814; -.
DR   CarbonylDB; Q7L2E3; -.
DR   GlyGen; Q7L2E3; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q7L2E3; -.
DR   MetOSite; Q7L2E3; -.
DR   PhosphoSitePlus; Q7L2E3; -.
DR   SwissPalm; Q7L2E3; -.
DR   BioMuta; DHX30; -.
DR   DMDM; 74758997; -.
DR   EPD; Q7L2E3; -.
DR   jPOST; Q7L2E3; -.
DR   MassIVE; Q7L2E3; -.
DR   MaxQB; Q7L2E3; -.
DR   PaxDb; 9606-ENSP00000405620; -.
DR   PeptideAtlas; Q7L2E3; -.
DR   ProteomicsDB; 68758; -. [Q7L2E3-1]
DR   ProteomicsDB; 68759; -. [Q7L2E3-2]
DR   ProteomicsDB; 68760; -. [Q7L2E3-3]
DR   Pumba; Q7L2E3; -.
DR   Antibodypedia; 13009; 186 antibodies from 23 providers.
DR   DNASU; 22907; -.
DR   Ensembl; ENST00000445061.6; ENSP00000405620.1; ENSG00000132153.15. [Q7L2E3-1]
DR   Ensembl; ENST00000446256.6; ENSP00000392601.3; ENSG00000132153.15. [Q7L2E3-1]
DR   Ensembl; ENST00000457607.1; ENSP00000394682.1; ENSG00000132153.15. [Q7L2E3-2]
DR   Ensembl; ENST00000619982.4; ENSP00000483160.1; ENSG00000132153.15. [Q7L2E3-3]
DR   GeneID; 22907; -.
DR   KEGG; hsa:22907; -.
DR   MANE-Select; ENST00000445061.6; ENSP00000405620.1; NM_138615.3; NP_619520.1.
DR   UCSC; uc003cru.4; human. [Q7L2E3-1]
DR   AGR; HGNC:16716; -.
DR   CTD; 22907; -.
DR   DisGeNET; 22907; -.
DR   GeneCards; DHX30; -.
DR   HGNC; HGNC:16716; DHX30.
DR   HPA; ENSG00000132153; Low tissue specificity.
DR   MalaCards; DHX30; -.
DR   MIM; 616423; gene.
DR   MIM; 617804; phenotype.
DR   neXtProt; NX_Q7L2E3; -.
DR   OpenTargets; ENSG00000132153; -.
DR   Orphanet; 647788; Neurodevelopmental delay-intellectual disability-ataxia-feeding difficulty syndrome.
DR   PharmGKB; PA27217; -.
DR   VEuPathDB; HostDB:ENSG00000132153; -.
DR   eggNOG; KOG0920; Eukaryota.
DR   GeneTree; ENSGT00940000158279; -.
DR   HOGENOM; CLU_001832_1_2_1; -.
DR   InParanoid; Q7L2E3; -.
DR   OMA; QYSCTEH; -.
DR   OrthoDB; 1095660at2759; -.
DR   PhylomeDB; Q7L2E3; -.
DR   TreeFam; TF352030; -.
DR   PathwayCommons; Q7L2E3; -.
DR   SignaLink; Q7L2E3; -.
DR   SIGNOR; Q7L2E3; -.
DR   BioGRID-ORCS; 22907; 155 hits in 1168 CRISPR screens.
DR   ChiTaRS; DHX30; human.
DR   EvolutionaryTrace; Q7L2E3; -.
DR   GenomeRNAi; 22907; -.
DR   Pharos; Q7L2E3; Tchem.
DR   PRO; PR:Q7L2E3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q7L2E3; Protein.
DR   Bgee; ENSG00000132153; Expressed in left testis and 175 other cell types or tissues.
DR   ExpressionAtlas; Q7L2E3; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0035770; C:ribonucleoprotein granule; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003678; F:DNA helicase activity; IBA:GO_Central.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0002151; F:G-quadruplex RNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; IDA:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR   GO; GO:1902775; P:mitochondrial large ribosomal subunit assembly; IMP:UniProtKB.
DR   CDD; cd17976; DEXHc_DHX30; 1.
DR   CDD; cd18791; SF2_C_RHA; 1.
DR   Gene3D; 1.20.120.1080; -; 1.
DR   Gene3D; 3.30.160.20; -; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR011709; DEAD-box_helicase_OB_fold.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR002464; DNA/RNA_helicase_DEAH_CS.
DR   InterPro; IPR007502; Helicase-assoc_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR18934; ATP-DEPENDENT RNA HELICASE; 1.
DR   PANTHER; PTHR18934:SF229; ATP-DEPENDENT RNA HELICASE DHX30; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF21010; HA2_C; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF07717; OB_NTP_bind; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00847; HA2; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00690; DEAH_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   Genevisible; Q7L2E3; HS.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm;
KW   Disease variant; Helicase; Hydrolase; Intellectual disability;
KW   Mitochondrion; Mitochondrion nucleoid; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Ribosome biogenesis; RNA-binding.
FT   CHAIN           1..1194
FT                   /note="ATP-dependent RNA helicase DHX30"
FT                   /id="PRO_0000245538"
FT   DOMAIN          53..121
FT                   /note="DRBM"
FT   DOMAIN          444..612
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          654..827
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..27
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          150..199
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           559..562
FT                   /note="DEAH box"
FT   BINDING         457..464
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99PU8"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..41
FT                   /note="MFSLDSFRKDRAQHRQRQCKLPPPRLPPMCVNPTPGGTISR -> MAAARRL
FT                   MALAAGISPRLQPLGPRAAGRQGRSRGFSSSCAHPDHTKEAAEAESGMAPGGPGEGDGS
FT                   LVN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_022118"
FT   VAR_SEQ         1..39
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036891"
FT   VAR_SEQ         40..41
FT                   /note="SR -> MA (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036892"
FT   VARIANT         493
FT                   /note="R -> H (in NEDMIAL; changed localization to stress
FT                   granules; decreased RNA-binding; no effect on RNA-dependent
FT                   ATPase activity; by inducing the formation of stress
FT                   granules probably indirectly decreases global protein
FT                   synthesis; dbSNP:rs1057519436)"
FT                   /evidence="ECO:0000269|PubMed:28327206,
FT                   ECO:0000269|PubMed:29100085"
FT                   /id="VAR_080611"
FT   VARIANT         562
FT                   /note="H -> R (in NEDMIAL; changed localization to stress
FT                   granules; decreased RNA-dependent ATPase activity; by
FT                   inducing the formation of stress granules probably
FT                   indirectly decreases global protein synthesis;
FT                   dbSNP:rs1060499733)"
FT                   /evidence="ECO:0000269|PubMed:28327206,
FT                   ECO:0000269|PubMed:29100085"
FT                   /id="VAR_080612"
FT   VARIANT         781
FT                   /note="G -> D (in NEDMIAL; changed localization to stress
FT                   granules; decreased RNA-dependent ATPase activity; by
FT                   inducing the formation of stress granules probably
FT                   indirectly decreases global protein synthesis;
FT                   dbSNP:rs1553706775)"
FT                   /evidence="ECO:0000269|PubMed:29100085"
FT                   /id="VAR_080613"
FT   VARIANT         782
FT                   /note="R -> W (in NEDMIAL; changed localization to stress
FT                   granules; decreased RNA-dependent ATPase activity; by
FT                   inducing the formation of stress granules probably
FT                   indirectly decreases global protein synthesis;
FT                   dbSNP:rs753242774)"
FT                   /evidence="ECO:0000269|PubMed:28327206,
FT                   ECO:0000269|PubMed:29100085"
FT                   /id="VAR_080614"
FT   VARIANT         785
FT                   /note="R -> C (in NEDMIAL; changed localization to stress
FT                   granules; decreased RNA-dependent ATPase activity; by
FT                   inducing the formation of stress granules probably
FT                   indirectly decreases global protein synthesis;
FT                   dbSNP:rs1085307451)"
FT                   /evidence="ECO:0000269|PubMed:29100085"
FT                   /id="VAR_080615"
FT   VARIANT         785
FT                   /note="R -> H (in NEDMIAL; changed localization to stress
FT                   granules; decreased RNA-dependent ATPase activity; by
FT                   inducing the formation of stress granules probably
FT                   indirectly decreases global protein synthesis;
FT                   dbSNP:rs1553706799)"
FT                   /evidence="ECO:0000269|PubMed:29100085"
FT                   /id="VAR_080616"
FT   CONFLICT        557
FT                   /note="I -> T (in Ref. 2; BAF83955)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1136
FT                   /note="R -> W (in Ref. 3; AAH14237)"
FT                   /evidence="ECO:0000305"
FT   TURN            47..49
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   HELIX           53..64
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   HELIX           67..73
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   STRAND          74..78
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   STRAND          81..91
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   STRAND          93..95
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   STRAND          97..105
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   HELIX           106..124
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   HELIX           136..144
FT                   /evidence="ECO:0007829|PDB:2DB2"
FT   MOD_RES         Q7L2E3-2:15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336"
SQ   SEQUENCE   1194 AA;  133938 MW;  33D9A08799FE7A02 CRC64;
     MFSLDSFRKD RAQHRQRQCK LPPPRLPPMC VNPTPGGTIS RASRDLLKEF PQPKNLLNSV
     IGRALGISHA KDKLVYVHTN GPKKKKVTLH IKWPKSVEVE GYGSKKIDAE RQAAAAACQL
     FKGWGLLGPR NELFDAAKYR VLADRFGSPA DSWWRPEPTM PPTSWRQLNP ESIRPGGPGG
     LSRSLGREEE EDEEEELEEG TIDVTDFLSM TQQDSHAPLR DSRGSSFEMT DDDSAIRALT
     QFPLPKNLLA KVIQIATSSS TAKNLMQFHT VGTKTKLSTL TLLWPCPMTF VAKGRRKAEA
     ENKAAALACK KLKSLGLVDR NNEPLTHAMY NLASLRELGE TQRRPCTIQV PEPILRKIET
     FLNHYPVESS WIAPELRLQS DDILPLGKDS GPLSDPITGK PYVPLLEAEE VRLSQSLLEL
     WRRRGPVWQE APQLPVDPHR DTILNAIEQH PVVVISGDTG CGKTTRIPQL LLERYVTEGR
     GARCNVIITQ PRRISAVSVA QRVSHELGPS LRRNVGFQVR LESKPPSRGG ALLFCTVGIL
     LRKLQSNPSL EGVSHVIVDE VHERDVNTDF LLILLKGLQR LNPALRLVLM SATGDNERFS
     RYFGGCPVIK VPGFMYPVKE HYLEDILAKL GKHQYLHRHR HHESEDECAL DLDLVTDLVL
     HIDARGEPGG ILCFLPGWQE IKGVQQRLQE ALGMHESKYL ILPVHSNIPM MDQKAIFQQP
     PVGVRKIVLA TNIAETSITI NDIVHVVDSG LHKEERYDLK TKVSCLETVW VSRANVIQRR
     GRAGRCQSGF AYHLFPRSRL EKMVPFQVPE ILRTPLENLV LQAKIHMPEK TAVEFLSKAV
     DSPNIKAVDE AVILLQEIGV LDQREYLTTL GQRLAHISTD PRLAKAIVLA AIFRCLHPLL
     VVVSCLTRDP FSSSLQNRAE VDKVKALLSH DSGSDHLAFV RAVAGWEEVL RWQDRSSREN
     YLEENLLYAP SLRFIHGLIK QFSENIYEAF LVGKPSDCTL ASAQCNEYSE EEELVKGVLM
     AGLYPNLIQV RQGKVTRQGK FKPNSVTYRT KSGNILLHKS TINREATRLR SRWLTYFMAV
     KSNGSVFVRD SSQVHPLAVL LLTDGDVHIR DDGRRATISL SDSDLLRLEG DSRTVRLLKE
     LRRALGRMVE RSLRSELAAL PPSVQEEHGQ LLALLAELLR GPCGSFDVRK TADD
//